Jeffrey Sippel, MD, MPH, discusses the trend of insurance claim denials related to non-invasive ventilators for patients with ALS.
There has been a trend of denied insurance claims for non-invasive ventilators (NIVs) by Medicare Advantage plans, particularly affecting individuals with amyotrophic lateral sclerosis (ALS), according to Jeffrey Sippel, MD, MPH, the associate director of Inpatient Clinical Services and associate professor of Clinical Medicine in the Pulmonary Sciences and Critical Care Medicine Division at the University of Colorado School of Medicine. In an interview with the American Journal of Managed CareⓇ (AJMCⓇ) he emphasized the adverse impact on patient outcomes and the financial shortsightedness of the carriers' approach, as appropriate admissions could potentially save significant health care costs in the long run.
Transcript
Could you shed light on the larger trend among Medicare Advantage plans? Why do you think this trend is emerging, and what are the consequences for patients?
So there are trends here that we've observed, and I would just say that United [Healthcare], by example, is the leader of the pack here, but there are absolutely other carriers that are following. And so, when we see trends for denials, one thing we need to ask ourselves is, “Are they right? And are these services medically indicated or not?” And they're telling us that they're not—I respectfully disagree.
They have a legalistic interpretation of a written document that's just not reality based. And so I think the main driver here—in fact, I know the main driver here—is cost. Back of the napkin, NIV machines might cost $15,000 to $20,000. The RAD (respiratory assist device) devices might cost $2000 to $3000. I get it. However, here's also the rest of the story. The DME company contracts for the NIV machines allow them to appropriately provide really good in home respiratory support. The bilevel devices get supported like CPAP—they just quite literally send patients masks and say, “Hey, try these, let us know which ones you like,” that's not appropriate. And when there are troubleshooting problems, they don't have the resources, because their contracts have much lower support for the bilevel devices, the RAD devices, they just don't provide the enhanced support.
So it's driven by money. It's driven by a lack of appreciation of how dynamic these patients are, and how quickly they can change from sort of stable to doing quite poorly. And then the final thing that they don't appreciate is that when we admit these patients appropriately, the costs associated with that admission are huge. They could have saved an admission and saved themselves tens of thousands of dollars. It's a short-sighted approach to making this quarter's profit statement look better.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More